Let’s talk

Pharmaceutical distribution · Pharmaceutical and life sciences

Principal claims and expiry recovery for pharma distributors, reconciled monthly

A pharmaceutical distributor works on a small trade margin and can lose most of it to claims its principals never settle. We reconcile expiry, breakage, scheme and rate-difference claims with each principal every month. What you are owed is then recovered rather than written off.

In one paragraph

Pharmaceutical distributors, stockists, super-stockists and carrying-and-forwarding agents usually turn over ₹25–500 crore and carry dozens of principals. They sit in the middle of the chain. They extend credit to chemists and hospitals, hold batch-wise stock for many companies, and depend on each principal to honour returns and schemes on its own terms. Owners and managing partners, often with the accounts manager, carry the gap between what is claimed and what is settled.

Who usually engages us

Owner or managing partner, often with the accounts manager

The economics

How the money moves in this trade

A distributor buys from principals at the price to stockist and sells to chemists and hospitals at the price to retailer. The trade margin between them is modest. On price-controlled medicines it is further limited, because the ceiling price is built on a notional retailer margin and cannot be exceeded. Volume, inventory turns and credit discipline decide whether that margin becomes profit. Schemes, bonus quantities and rate changes complicate the arithmetic, and each principal runs them differently.

The larger exposure sits in claims. Expired and breakage stock returned by chemists has to be passed back to the principal. Scheme benefits passed on to retailers have to be reclaimed, and price reductions on stock already held create rate-difference claims. Principals settle these on their own timetables and policies, often by credit note. A distributor that does not track every claim to settlement can lose more to unrecovered claims than it earns on some principals' products.

The problem

Where the numbers usually break down

Claims are tracked by principal, not by claim

Expiry, breakage, scheme and rate-difference claims are lodged and then followed up from memory. The total outstanding from each principal is unknown, and old claims lapse.

Expiry returns from chemists are accepted without matching

Returns are taken back from retailers without checking the batch was supplied by you, so stock bought elsewhere ends up as your loss.

Principal credit notes are not matched to claims

Credit notes arrive in bulk without reference to the claims they settle, so short settlements are absorbed without being noticed.

Chemist credit is extended without limits

Retail and hospital customers are allowed to run up balances with no defined limit or ageing review, and the oldest dues become bad debts.

Batch-wise stock is not agreed with the books

The billing software holds batch-level stock, but it is not reconciled with physical stock or the ledger, so near-expiry exposure is unknown.

What we do

The work, and the result each part produces

Claim register by principal

Every expiry, breakage, scheme and rate-difference claim logged with its evidence, aged, and followed to settlement.

You know what each principal owes and how long it has owed it.

Credit-note matching

Principal credit notes matched to the claims they settle, with short and rejected amounts reported for follow-up.

Short settlements are visible and challenged.

Expiry return controls

Retailer returns checked against your own sales by batch and invoice before credit is given.

Expiry losses are limited to stock you actually supplied.

Chemist and hospital credit control

Credit limits, ageing reviews and collection follow-up by customer and route.

Receivables stay within terms and bad debts fall.

Batch-wise stock reconciliation

Physical stock, system stock by batch and the ledger reconciled on a fixed cycle, with near-expiry stock flagged for return or liquidation.

Expiry exposure is known before stock becomes unsaleable.

Principal-wise profitability

Contribution by principal after trade margin, schemes, unrecovered claims, freight and working capital.

You can see which agencies are worth the capital they consume.

Where we start

The first steps of an engagement

  1. Claim files and billing data

    We ask for the claims lodged with each principal and their evidence, principal credit notes, retailer return records by batch, the billing software's batch-wise stock and sales, and the receivables ledger.

  2. Claims against credit notes

    We match credit notes received to the claims they settle, principal by principal. Old claims still open, short settlements and rejections are listed with their evidence.

  3. Return check before credit

    Retailer expiry returns are checked against your own sales by batch and invoice before any credit is given. Stock you did not supply goes back to the retailer.

  4. Principal claims report

    The first report shows claims outstanding by principal and age, claims settled against claims lodged, and near-expiry stock by principal that can still be returned.

How it is measured

The reports the work is judged on

Each is recorded as a baseline before the work starts, so later reports have an honest comparison.

  • Claims outstanding by principal and age
  • Claims settled against claims lodged
  • Expiry returns accepted against own-supply evidence
  • Chemist and hospital receivables by age
  • Near-expiry stock by principal and month
  • Contribution by principal, after unrecovered claims

Who it suits

Written for, and not the right fit for

Not the right fit if
  • You need help with drug licences for wholesale or with a drug inspector's queries; those sit with you and the licensing authority.
  • You want a new distribution software selected and implemented; we work inside the systems you already run.
Written for
  • Pharmaceutical distributors and super-stockists carrying many principals.
  • Carrying-and-forwarding agents managing depot stock and claims for manufacturers.
  • Owner-run distributors whose growth has outrun their billing software's reports.

Common questions

Questions owners in this trade ask

How much do pharma distributors lose in unrecovered claims?

We don't publish a figure, because it varies widely by principal and by how claims are tracked. The register itself shows your own number within the first month or two, which is the one that matters.

Will this work with our distribution billing software?

Yes. Most pharmaceutical billing software already holds batch-level sales and returns. The work is in using that data to match returns and claims, not in replacing the system.

Do you handle drug licences or inspections?

No. Licensing and inspection are matters between you and the authority. We work on the finance side — claims, stock, credit and controls.

Scope and professional coordination

5th Quadrant performs accounting, reconciliation, credit-control and reporting work. Drug licensing for wholesale and storage, and any inspection by the licensing authority, are the distributor's own responsibility. Statutory audit and tax-audit reports are performed by independently engaged licensed professionals. Full detail is on our Professional Scope page.

Explore further

Other trades in this sector

Back to Pharmaceutical and life sciences ↗

Tell us how your business actually runs.

Discuss your requirements